Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Acute myeloid leukaemia in patients we judge as being older and/or unfit
Vladimir Lazarević
Journal of Internal Medicine (2021) Vol. 290, Iss. 2, pp. 279-293
Closed Access | Times Cited: 13

Showing 13 citing articles:

Global, regional, and national burden of leukemia, 1990–2021: a systematic analysis of the global burden of disease in 2021
Jiaxi Chen, Wenyi Pang, Miao Deng, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Hematopoiesis, Inflammation and Aging—The Biological Background and Clinical Impact of Anemia and Increased C-Reactive Protein Levels on Elderly Individuals
Øystein Bruserud, Anh Khoi Vo, Håkon Rekvam
Journal of Clinical Medicine (2022) Vol. 11, Iss. 3, pp. 706-706
Open Access | Times Cited: 15
Metformin as an Enhancer for the Treatment of Chemoresistant CD34+ Acute Myeloid Leukemia Cells
Indre Krastinaite, Sergej Charkavliuk, Rūta Navakauskienė, et al.
Genes (2024) Vol. 15, Iss. 5, pp. 648-648
Open Access | Times Cited: 2
CARving the Path to Allogeneic CAR T Cell Therapy in Acute Myeloid Leukemia
Oren Pasvolsky, May Daher, Gheath Alatrash, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 11
Molecular Secrets Revealed: How Diabetes may be Paving the Way for Leukemia
Pouya Goleij, Mohammad Amin Khazeei Tabari, Ahmed Ahmed, et al.
Current Treatment Options in Oncology (2024)
Closed Access | Times Cited: 1
Incorporation of a Comorbidity Index in Treatment Decisions for Elderly AML Patients Can Lead to Better Disease Management—A Single-Center Experience
Cristina Negotei, Iuliana Mitu, Silvana Angelescu, et al.
Hematology Reports (2024) Vol. 16, Iss. 4, pp. 781-794
Open Access | Times Cited: 1
CD123 Antagonistic Peptides Assembled with Nanomicelles Act as Monotherapeutics to Combat Refractory Acute Myeloid Leukemia
Shilin Xu, Meichen Zhang, Xiaocui Fang, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 34, pp. 38584-38593
Closed Access | Times Cited: 5
Hypomethylating agents plus modified priming regimens compared with venetoclax-based regimens based on molecular characteristics for newly diagnosed patients with acute myeloid leukemia: a multi-center cohort study
Guangyang Weng, Jingya Huang, Xin He, et al.
Annals of Hematology (2023) Vol. 102, Iss. 12, pp. 3369-3381
Closed Access | Times Cited: 2
Roles of Glutathione and AP-1 in the Enhancement of Vitamin D-Induced Differentiation by Activators of the Nrf2 Signaling Pathway in Acute Myeloid Leukemia Cells
Yasmeen Jramne-Saleem, Michael Danilenko
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2284-2284
Open Access
Short-term Group Venetoclax Combined with Azacitidine for Treating Newly Diagnosed Elderly Acute Myeloid Leukemia: A Retrospective Study
Zhuruohan Yu, Shuangyue Li, Renzhi Pei, et al.
(2024)
Closed Access
Outcomes of allogeneic stem cell transplantation for patients with hematologic diseases ≥60 years old
Takahiro Shima, Ken Takigawa, Sae Utsumi, et al.
BLOOD CELL THERAPY / The official journal of APBMT (2023) Vol. 6, Iss. 2
Open Access | Times Cited: 1
Comparative Efficacy of Venetoclax-Based Combination Therapies and Other Therapies in Treatment-Naive Patients With Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy: A Network Meta-Analysis
Xue Li, Hae Sun Suh, J. Lachaine, et al.
Value in Health (2023) Vol. 26, Iss. 12, pp. 1689-1696
Closed Access | Times Cited: 1
Roles of Glutathione and AP-1 in the Enhancement of Vitamin D-induced Differentiation by Activators of the Nrf2 Signaling Pathway in Acute Myeloid Leukemia Cells
Yasmeen Jramne-Saleem, Michael Danilenko
(2023)
Open Access | Times Cited: 1
Venetoclax in Acute Myeloid Leukemia
Romeo-Gabriel Mihăilă
Recent Patents on Anti-Cancer Drug Discovery (2022) Vol. 18, Iss. 1, pp. 11-28
Closed Access | Times Cited: 2
Page 1

Scroll to top